[1]
Qu, J., Li, J., Ma, Y. and Wang, Z. 2023. Sanggenon C inhibits proliferation of breast cancer cells and reduces HIF-1α/VEGF pathway activity under hypoxia conditions. Tropical Journal of Pharmaceutical Research. 22, 8 (Sep. 2023), 1553–1559. DOI:https://doi.org/10.4314/tjpr.v22i8.4.